$HWELU $HWEL $HWELW Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
https://www.stocktitan.net/news/HWELU/healthwell-acquisition-corp-i-announces-cancellation-of-special-cw0z0391820a.html
$HWELU $HWEL $HWELW Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
https://www.stocktitan.net/news/HWELU/healthwell-acquisition-corp-i-announces-termination-of-business-ky6vwufbw059.html
$HWEL $HWELU Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
https://www.stocktitan.net/news/HWEL/starton-therapeutics-announces-termination-of-business-combination-xpvp6v1tjgnj.html
$HWEL Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
https://www.stocktitan.net/news/HWEL/healthwell-acquisition-corp-i-announces-postponement-of-the-special-skhfmr1719zp.html
$HWELU $HWEL Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions
https://www.stocktitan.net/news/HWELU/healthwell-acquisition-corp-i-announces-new-meeting-date-for-the-24iwf38g880r.html
#SPMNOTES:
$ZBRA demonstrated a Generative Artificial Intelligence large language model running on Zebra handheld mobile computers and tablets without needing connectivity to the cloud.
Starton Therapeutics announces the dosing of the first patient in the STAR-LLD Phase 1b clinical trial, which will assess the safety, efficacy and pharmacokinetics of continuous subcutaneous administration of low-dose lenalidomide for the treatment of multiple myeloma. Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I ($HWEL).
Butterfly Network ($BFLY) and Razom announce that they have expanded their global health partnership to bring an additional 200 Butterfly iQ+ devices to the frontlines of the war in Ukraine. Razom has now alone deployed over 400 Butterfly iQ+ devices to Ukraine, and has been a leader in driving Point-of-Care Ultrasound training and utilization in the country.
$HWEL $HWELU Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma
https://www.stocktitan.net/news/HWEL/starton-therapeutics-announces-the-opening-of-the-first-clinical-6bwhh766hwob.html
